Welcome to COMPPARE
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer. Patient enrollment in COMPPARE closed October 31, 2022.
Visit Our newsROOM
Early COMPPARE Results Presented at ASCO
Two-year findings were discussed at ASCO in Chicago on May 31, but assessing long-term comparative outcomes like disease control, late toxicity and…
The Importance of the Primary Completion Date
When you volunteered for COMPPARE, you might have heard about something its PCD. But what does that mean for you, really?
Why Your Participation in COMPPARE Matters More…
Our most critical insights will come years after treatment ends, as long-term follow-up is essential to understanding lasting effects and benefits.
For participants
For Healthcare providers
Consortium Materials
Study-specific materials and other information.
ClinicalTrials.gov
Privately and publicly funded clinical studies conducted around the world.